Analisi dello stato delle attività di centralizzazione delle terapie oncologiche nella Regione Veneto

Translated title of the contribution: Analysis of the state of the activities centralisation oncologiche therapy in the region veneto

Silvia Adami, Angelo Palozzo, Valentina Fantelli, Mario Saia, Giovanna Scroccaro

Research output: Contribution to journalArticle

Abstract

In Italy, all cytotoxic medications must be handled following the Italian Pharmacopeia rules "Norme di Buona Preparazione". Customizing a dosage of an injectable drug is equivalent to prepare a galenic medication, then it should be done under the responsability of a pharmacist. Therefore, the objective of this report is to describe the analysis conducted on the process for the centralized management of antiblastic agents in ULSS Companies, Hospital Companies, IRCCS and private hospitals accredited by the Veneto Region, with special focus on the role and responsibilities of hospital pharmacists in the handling of chemotherapeutic drugs. The analysis of the responses received shows that more than 60% of the hospitals have centralized the procedures within a Unit for cytotoxic drug preparations [Unità Farmaci Antiblastici (UFA)] under the responsibility and coordination of the hospital pharmacist or entered into agreements with UFAs nearby. Finally, Veneto Region Deliberation n. 1335 of July 28th, 2014 established the implementation of the Recommendations n. 14 on preventing errors in anticancer drug therapy and defined the standards for centralizing the oncology therapies in the Veneto Region.

Original languageItalian
Pages (from-to)119-125
Number of pages7
JournalGiornale Italiano di Farmacia Clinica
Volume29
Issue number2
DOIs
Publication statusPublished - Apr 1 2015

Fingerprint

Pharmacists
Drug Compounding
Private Hospitals
Pharmacopoeias
Therapeutics
Pharmaceutical Preparations
Italy
Drug Therapy
Injections

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Analisi dello stato delle attività di centralizzazione delle terapie oncologiche nella Regione Veneto. / Adami, Silvia; Palozzo, Angelo; Fantelli, Valentina; Saia, Mario; Scroccaro, Giovanna.

In: Giornale Italiano di Farmacia Clinica, Vol. 29, No. 2, 01.04.2015, p. 119-125.

Research output: Contribution to journalArticle

Adami, Silvia ; Palozzo, Angelo ; Fantelli, Valentina ; Saia, Mario ; Scroccaro, Giovanna. / Analisi dello stato delle attività di centralizzazione delle terapie oncologiche nella Regione Veneto. In: Giornale Italiano di Farmacia Clinica. 2015 ; Vol. 29, No. 2. pp. 119-125.
@article{68809a96c61e4a4fab1553827b5203f2,
title = "Analisi dello stato delle attivit{\`a} di centralizzazione delle terapie oncologiche nella Regione Veneto",
abstract = "In Italy, all cytotoxic medications must be handled following the Italian Pharmacopeia rules {"}Norme di Buona Preparazione{"}. Customizing a dosage of an injectable drug is equivalent to prepare a galenic medication, then it should be done under the responsability of a pharmacist. Therefore, the objective of this report is to describe the analysis conducted on the process for the centralized management of antiblastic agents in ULSS Companies, Hospital Companies, IRCCS and private hospitals accredited by the Veneto Region, with special focus on the role and responsibilities of hospital pharmacists in the handling of chemotherapeutic drugs. The analysis of the responses received shows that more than 60{\%} of the hospitals have centralized the procedures within a Unit for cytotoxic drug preparations [Unit{\`a} Farmaci Antiblastici (UFA)] under the responsibility and coordination of the hospital pharmacist or entered into agreements with UFAs nearby. Finally, Veneto Region Deliberation n. 1335 of July 28th, 2014 established the implementation of the Recommendations n. 14 on preventing errors in anticancer drug therapy and defined the standards for centralizing the oncology therapies in the Veneto Region.",
keywords = "Antiblastic drugs, Hospital pharmacist",
author = "Silvia Adami and Angelo Palozzo and Valentina Fantelli and Mario Saia and Giovanna Scroccaro",
year = "2015",
month = "4",
day = "1",
doi = "10.1721/1878.20510",
language = "Italian",
volume = "29",
pages = "119--125",
journal = "Giornale Italiano di Farmacia Clinica",
issn = "1120-3749",
publisher = "Il Pensiero Scientifico Editore s.r.l.",
number = "2",

}

TY - JOUR

T1 - Analisi dello stato delle attività di centralizzazione delle terapie oncologiche nella Regione Veneto

AU - Adami, Silvia

AU - Palozzo, Angelo

AU - Fantelli, Valentina

AU - Saia, Mario

AU - Scroccaro, Giovanna

PY - 2015/4/1

Y1 - 2015/4/1

N2 - In Italy, all cytotoxic medications must be handled following the Italian Pharmacopeia rules "Norme di Buona Preparazione". Customizing a dosage of an injectable drug is equivalent to prepare a galenic medication, then it should be done under the responsability of a pharmacist. Therefore, the objective of this report is to describe the analysis conducted on the process for the centralized management of antiblastic agents in ULSS Companies, Hospital Companies, IRCCS and private hospitals accredited by the Veneto Region, with special focus on the role and responsibilities of hospital pharmacists in the handling of chemotherapeutic drugs. The analysis of the responses received shows that more than 60% of the hospitals have centralized the procedures within a Unit for cytotoxic drug preparations [Unità Farmaci Antiblastici (UFA)] under the responsibility and coordination of the hospital pharmacist or entered into agreements with UFAs nearby. Finally, Veneto Region Deliberation n. 1335 of July 28th, 2014 established the implementation of the Recommendations n. 14 on preventing errors in anticancer drug therapy and defined the standards for centralizing the oncology therapies in the Veneto Region.

AB - In Italy, all cytotoxic medications must be handled following the Italian Pharmacopeia rules "Norme di Buona Preparazione". Customizing a dosage of an injectable drug is equivalent to prepare a galenic medication, then it should be done under the responsability of a pharmacist. Therefore, the objective of this report is to describe the analysis conducted on the process for the centralized management of antiblastic agents in ULSS Companies, Hospital Companies, IRCCS and private hospitals accredited by the Veneto Region, with special focus on the role and responsibilities of hospital pharmacists in the handling of chemotherapeutic drugs. The analysis of the responses received shows that more than 60% of the hospitals have centralized the procedures within a Unit for cytotoxic drug preparations [Unità Farmaci Antiblastici (UFA)] under the responsibility and coordination of the hospital pharmacist or entered into agreements with UFAs nearby. Finally, Veneto Region Deliberation n. 1335 of July 28th, 2014 established the implementation of the Recommendations n. 14 on preventing errors in anticancer drug therapy and defined the standards for centralizing the oncology therapies in the Veneto Region.

KW - Antiblastic drugs

KW - Hospital pharmacist

UR - http://www.scopus.com/inward/record.url?scp=84942240363&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942240363&partnerID=8YFLogxK

U2 - 10.1721/1878.20510

DO - 10.1721/1878.20510

M3 - Articolo

VL - 29

SP - 119

EP - 125

JO - Giornale Italiano di Farmacia Clinica

JF - Giornale Italiano di Farmacia Clinica

SN - 1120-3749

IS - 2

ER -